Oncology claims are the clearest stress test of an annual limit, because they arrive as a sequence rather than an event. This case documents every invoice in a CHOP protocol for a seven-year-old Golden Retriever and what the policy paid at each stage.
The facts
Seven-year-old female Golden Retriever, insured from ten weeks, continuous cover, no prior claims. Presented with enlarged submandibular lymph nodes; fine-needle aspirate and histopathology confirmed multicentric lymphoma.
Treatment: a 19-week CHOP-based protocol at a referral oncology service, with supportive care and monitoring bloodwork throughout.
The invoices
Diagnostics: consultation $240, aspirate and cytology $310, histopathology $420, staging radiographs $290, abdominal ultrasound $460, bloodwork $260. Subtotal $1,980.
Protocol: induction weekly visits at $420 to $520 each for nine weeks ($4,140), then biweekly visits for ten weeks ($2,380). Monitoring bloodwork $95 at each visit, sixteen times ($1,520). Supportive medication $85 per month for five months ($425).
Two hospitalisations for febrile neutropenia: $1,010 and $975. Total invoiced across the protocol: $11,430.
| Stage | Invoiced | Cumulative paid |
|---|---|---|
| Diagnostics | $1,980 | $1,264 |
| Induction (weeks 1–9) | $4,140 | $4,476 |
| Monitoring bloodwork | $1,520 | $5,448 |
| Continuation (weeks 10–14) | $2,380 | $7,940 |
| Febrile neutropenia x2 | $1,985 | $9,940 |
| Weeks 15–19 | $1,430 | $10,000 (cap) |
The decision
Deductible $400 applied once at the start. Reimbursement 80%. Annual limit $10,000, no per-condition cap.
By week fourteen the policy had paid $9,940 of the $10,000 limit. The remaining invoices — $1,430 invoiced — paid $48. The owner funded $1,442 to finish the protocol, plus the deductible and the 20% share throughout.
Total paid by insurer: $10,000. Total paid by owner: $2,286.
What would have changed it
An unlimited or $15,000 annual limit. The premium difference was around $14 a month at purchase.
Timing: had the protocol started eight weeks later, most of it would have fallen into the following policy year and the limit would have reset mid-protocol. This is a legitimate conversation to have with the oncologist, and it is not unusual.
- A lymphoma protocol produces a dozen or more separate invoices.
- Monitoring bloodwork alone consumed over $1,500 of limit.
- The limit, not the reimbursement rate, ended the cover.
- Timing the protocol around the policy year is a legitimate lever.
If a protocol can start after your renewal date without harming the dog, up to a full annual limit becomes available mid-treatment. It is a financial conversation worth having explicitly.
Key takeaways
- Oncology claims are sequences, not events.
- Annual limits should be $15,000 or unlimited for cancer-prone breeds.
- Supportive and diagnostic costs count against the same limit.
- Policy-year timing can materially change the total covered.
